Dipyridamole Bound to the SARS-CoV-2 Protease Mpro (IMAGE)

Compuscript Ltd

Dipyridamole Bound to the SARS-CoV-2 Protease Mpro

Caption

Dipyridamole bound to the SARS-CoV-2 protease Mpro after identified via the virtual screening and bioassay validation, and thus suppressed viral replication in vitro. As a result, dipyridamole supplementation was associated with significantly decreased concentrations of D-dimers, increased lymphocyte and platelet recovery in the circulation, and markedly improved clinical outcomes in comparison to the control patients.

Credit

Acta Pharmaceutica Sinica B

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.